Xolair in Patients With Chronic Sinusitis
NCT00117611
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
14
Enrollment
OTHER
Sponsor class
Conditions
Sinusitis
Interventions
DRUG:
Anti-IgE antibody omalizumab or placebo
Sponsor
University of Chicago
Collaborators
[object Object]
[object Object]